01280nas a2200157   4500000000100000008004100001260001200042100001600054700001900070245006500089856005800154300001400212490000800226520087400234022001401108       2017                            d  c2017-101 aLucie A Low1 aDanilo A Tagle00aOrgans-on-chips: Progress, challenges, and future directions  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661765/  a1573-15780 v2423 aThe National Institutes of Health Microphysiological Systems (MPS) program, led by the National Center for Advancing Translational Sciences, is part of a joint effort on MPS development with the Defense Advanced Research Projects Agency and with regulatory guidance from FDA, is now in its final year of funding. The program has produced many tangible outcomes in tissue chip development in terms of stem cell differentiation, microfluidic engineering, platform development, and single and multi-organ systems—and continues to help facilitate the acceptance and use of tissue chips by the wider community. As the first iteration of the program draws to a close, this Commentary will highlight some of the goals met, and lay out some of the challenges uncovered that will remain to be addressed as the field progresses. The future of the program will also be outlined.  a1535-3702